z-logo
Premium
Embryo Biopsy for Stem Cells: Trading Old Problems for New
Author(s) -
HUDSON KATHY L.
Publication year - 2006
Publication title -
hastings center report
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.515
H-Index - 63
eISSN - 1552-146X
pISSN - 0093-0334
DOI - 10.1353/hcr.2006.0078
Subject(s) - embryo , stem cell , embryonic stem cell , biology , embryo transfer , stalemate , microbiology and biotechnology , genetics , politics , law , political science , gene
The team of scientists at Advanced Cell Technology led by Robert Lanza has announced that it has developed a method to create stem cells from a single cell extracted from a human embryo without destroying the embryo. Heralded by some as the perfect solution to the political stalemate over funding stem cell research, Lanza's work--at the moment--raises as many questions as it answers. Currently, scientists harvest stem cells from early-stage embryos, usually excess embryos from IVF that would otherwise be discarded. The embryo is destroyed in the process. Lanza asserts that scientists could remove one cell from an early-stage human embryo to create a new stem cell line, preserving the remaining embryo for transfer to a woman's womb to initiate a pregnancy. A similar technique--under the name preimplantation genetic diagnosis--is used rather routinely in IVF clinics. In PGD, the cell undergoes genetic analysis in order to test embryos for genetic diseases or conditions. Lanza also suggests--although he did not test the claim experimentally--that a single cell removed from the embryo could be used simultaneously for dual purposes: Let it grow and divide overnight, he says, and use the resulting multiple cells both to perform PGD and to grow stem cell lines. If PGD shows the embryo to be unaffected it can be transferred to a woman's womb. Theoretically, he points out, if the stem cell lines develop successfully, the new baby will have his or her very own stem cell line from which matched tissue or other therapies can be grown. So what's wrong with this picture? First, taking a cell from an embryo brings risk--how much risk is unknown. It's a touchy time for a young embryo--intercellular communication networks are being set up and a host of other critical functions are being initialized. Moreover, removing a single cell from a tiny embryo requires "good hands" on the part of a lab technician--and even with the best of hands, some embryos don't survive. Biopsied embryos survive freezing much less well than intact embryos, and some evidence suggests embryos that survive the biopsy are not as good at implanting in the womb. It is thus almost certainly a nonstarter to ask couples going through IVF to contribute a cell for stem cell research. The risks of embryo biopsy could reduce the likelihood that IVF would succeed. The prospective parents already have only about a one-in-three chance of having a baby from any given IVF cycle. The odds are reduced if the embryo's viability is impaired, and reduced even more if a biopsied embryo is frozen for later transfer. These doubts led Lanza and his colleagues to suggest that this approach to stem cell research be used only in the context of PGD. Lanza's logic is that if prospective parents contemplating PGD can still get the benefit of genetic analysis, they would not object if the blastomere removed for genetic analysis also gives rise to stem cells, and especially not if it gives their future offspring the chance to have matched stem cell lines for potential future therapeutic use. …

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here